Preserving at least three parathyroid glands is key to avoiding permanent hypoparathyroidism — resulting in abnormally low calcium levels in the blood and bones, and an increase in phosphorus in the blood — after thyroid removal surgery, research shows. The study, “Hypoparathyroidism After Total Thyroidectomy: Importance…
Maintaining serum calcium levels within the low normal reference range, checking them closely, and assuring a coordinated approach among health professionals are among the recommendations for pregnant women with hypoparathyroidism, according to a review study. The study, “Hypoparathyroidism in Pregnancy: Review and Evidence Based Recommendations for Management,”…
Iranian patients with Sanjad-Sakati syndrome (SSS) show specific gene mutations associated with hypoparathyroidism, severe growth failure, and facial structural alterations, according to a study. The study, “Clinical features and tubulin folding cofactor E gene analysis in Iranian patients with Sanjad—Sakati syndrome,” appeared in the…
Treatment with the injectable parathyroid hormone Natpara slows the decline in kidney function in patients with chronic hypoparathyroidism, according to recent clinical trial data. Natpara, developed by Shire, is a recombinant human parathyroid hormone (rhPTH[1-84]) approved as an add-on to the conventional treatment of chronic hypoparathyroidism with calcium and activated…
Get regular updates to your inbox.
